| March 18, 2004 |
|
|
|
CMS
Clinical Laboratory Improvement Amendments
New Waived Tests
CMS released a list of new CLIA waived tests. The implementation date for these is April 5, 2004.
CPT-4 Code/ Modifier |
Effective Date |
Description |
87899QW |
08-21-2003 |
Binax NOW RSV Test |
87899QW |
08-29-2003 |
Integrated Biotechnology Quick Lab RSV Test |
86701QW |
09-30-2003 |
OraSure OraQuick Rapid HIV-1 Antibody Test – fingerstick and venipuncture
whole blood |
82274QW G0328QW |
10-16-2003 |
Enterix InSure Fecal Immunochemical Test |
87880QW |
10-21-2003 |
Germaine Laboratories Strep AIM Tower |
Reference: Change Request 3061;
Transmittal 102; Pub. 100-04. |
|
Coordination of Benefits Agreement (COBA)
CMS issued CR 3109 on the implementation of a new initiative known as the Coordination of Benefits Agreement (COBA)
consolidated crossover process, which changes the existing Medicare claims crossover process. The Coordination of
Benefits Contractor (COBC) will assign unique five-digit COBA IDs to Medigap and Medicaid insurers that do not
provide eligibility files to the COBC. Effective October 4, 2004 all Part B providers must cease including the
Carrier issued Medigap or Medicaid ID on incoming claims and replace them with the claim-based COBA ID.
Reference: MM3109,
Medlearn Matters, Related Change Request 3109.
|
|
Elimination of Grace Period for Discontinued Codes
CMS issued Transmittal 94 (published February 6, 2004) on the elimination of the 90-day grace period for discontinued
ICD-9-CM diagnosis codes effective October 1, 2004.
CMS issued Transmittal 89 (published February 6, 2004) on the elimination of the 90-day grace period for discontinued
CPT and HCPCS codes effective January 1, 2005.
Claims with discontinued codes will be returned as unproccessable after the respective policy effective dates noted
above.
Reference: MM3094,
Medlearn Matters, Related Change Request 3094.
| |
HIPAA
Modified HIPAA Contingency Plan
CMS has issued CR 2981 on modifying the Health Insurance Portability and Accountability Act (HIPAA) contingency
plan, effective July 1, 2004. Medicare will continue to allow submission of non-compliant electronic claims. However,
the payment of electronic claims that are not HIPAA compliant will take thirteen additional days.
Reference: MM2981,
Medlearn Matters, Related Change Request 2981.
View the Change Request 2981,
Transmittal 114; Pub. 100-04.
| |
NCD
Laboratory National Coverage Determination - Update
CMS published their April update for NCDs. The only lab procedure updated is the Serum Iron Studies, CPT codes:
The following diagnosis codes are added to the list of ICD-9 codes covered by Medicare:
- 403.01, Hypertensive renal disease, malignant, with renal failure
- 403.11, Hypertensive renal disease, benign, with renal failure
- 403.91, Hypertensive renal disease, unspecified, with renal failure
- 404.02, Hypertensive heart and renal disease, malignant, with renal failure
- 404.03, Hypertensive heart and renal disease, malignant, with heart and renal failure
- 404.12, Hypertensive heart and renal disease, benign, with renal failure
- 404.13, Hypertensive heart and renal disease, benign, with heart and renal failure
- 404.92, Hypertensive heart and renal disease, unspecified, with renal failure
- 404.93, Hypertensive heart and renal disease, unspecified, with heart and renal failure
Reference: NCD Index. |
| |
Remittance Advice Remark Codes
26 Feb 2004
The Remittance Advice Remark Code and Claim Adjustment Reason Codes are updated.
View the Remark
Reason Codes 02/04, Change Request 3122; Transmittal 93; Publication 100-04.
| |
California - NHIC Medicare
Apolipoproteins
Apolipoproteins (82172) was denied last year as medically unnecessary. NHIC revised their policy and will
now go back and automatically re-pay everything denied 2/26/03-5/31/03, per Michele Kelly at NHIC. |
|
Duplicate Billing Denials
NHIC issues its largest volume of denials for duplicate billings. The handling of these services is expensive
to both providers and the Medicare program. NHIC strongly discourages providers from configuring their systems to
automatically rebill outstanding claims after 30 days. Electronic claims are settled after 14 days while paper
claims are settled after 28 days. NHIC recommends providers build edits into their systems to avoid duplicate
submissions. NHIC encourages providers to stay current with posting every claim from their remittance advice(s)
into their system, including denials. If a procedure is performed multiple times on the same day, use ICD-9-CM
codes, modifiers and documentation to identify different sites, sessions or specimens.
Reference: "Duplicate
Billing" on the NHIC website for California providers, posted January 22, 2004. |
|
New Medical Director for CA
26 Feb 2004
National Heritage Insurance Company (NHIC) announced the acceptance by Bruce Quinn, MD/PhD, MBA of the position as NHIC
California Carrier Medical Director (CMD).
Reference: New
Medical Director. |
|
California Medi-Cal
FPACT HPV Testing
Human Papilloma Virus (HPV) Reimbursement Update
Effective for dates of service on or after April 1, 2004, the following CPT-4 Human Papilloma Virus (HPV)
procedure codes are no longer reimbursable:
CPT-4 Code |
Description |
|
87620 |
Infectious agent detection by nucleic acid (DNA or RNA), papilloma virus, human,
direct probe technique |
|
87622 |
Quantification |
|
|
|
|
In addition, CPT-4 HPV procedure code 87621 (...amplified probe technique) is restricted
as follows: |
- Limited to one claim every eleven months for the same recipient, by any provider
- Screening for high-risk HPV types only
- By Report: Attach cervical cytology report indicating the presence of atypical squamous cells
of undetermined significance (ASC-US) for females of all ages or non-reflex testing for females less than 21 years
of age with a cervical cytology report of low-grade squamous intraepithelial lesion (LSIL)
|
A future update will include the revised Family PACT Policies, Procedures and Billing Instructions
(PPBI) manual. For more information regarding Family PACT, call the Telephone Service
Center (TSC) at 1-800-541-5555. |
| | |
New York - EMPIRE Medicare Service
Local Coverage Determination
New York Empire published the following policy in Notice Period and will have an effective date of April 19, 2004.
LBO14E00 |
Immunoassay for Bladder Cancer |
CPT |
86294 |
Changes: |
ICD9-CM codes 198.1, 233.3, 236.7 and V71.1 were deleted information on new technology for NMP22
BladderChek test was added under INDICATIONS. |
|
Reference: Local Coverage
Determination, EMPIRE Medicare Service.
|
|
|
| | |
| |
| |
|
"Reimbursement Issues In Molecular Diagnostics"
2004 Executive War College On Lab and Pathology Management: April 29th 2004
"... Gain an understanding of how national and regional payers are responding
to claims for these new molecular tests..."
Presenter: Lale White, CEO, XIFIN, Inc.
For more information: Dark Report,
Executive War College.
|
| |
| |
|
Disclaimer: The pages in this section contain external links that are not the responsibility nor under the
control of XIFIN. XIFIN cannot attest to the accuracy, currency, or comprehensiveness of the information on
any other site pages--such data are entirely the responsibility of the Webmaster of the site visited.
Furthermore, XIFIN does not endorse any commercial products or services that might be mentioned on these sites.
|
|
This information is provided by XIFIN, Inc. This is a post only service. E-mail questions or comments
directly to XIFIN Info@xifin.com
|
|
You are currently subscribed to the XIFIN Newsletter. You can cancel your subscription
by sending a message, from the e-mail account where you are subscribed,
to: Info@xifin.com.
|
| |
|
Return to Top
|
| Contact Us | Privacy Statement |
Legal
|
| © 2004 XIFIN®, Inc. All rights reserved.
|
|
|